BMRN
BioMarin Pharmaceutical Inc. · Healthcare
CEO Jean Jacques Bienaime sold $712K of BioMarin Pharmaceutical Inc.
Sold$712,388
$85.49Price
8,333Shares
−2%Stake
What BMRN did after the filing
Prices for BMRN after this filing aren't in yet.
Traded Wed, Jan 27. Filed Thu, Jan 28, 7:35 PM ET, after the close. Not investment advice.